Category Archives: Reasearch

18Mar/23

New Co-Authored Study Opens New Doors to Quantum-Powered Machine Learning and Medical Diagnostics

QC Ware, a leading quantum software and services company, announced today that a joint research project with one of the world’s leading biotechnology companies uncovered new discoveries in medical imaging analysis and diagnostics, leveraging quantum computing to better detect the presence and type of diabetic retinopathy. Continue reading

13Mar/23

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
Proposed combination enhances Pfizer’s position as a leading company in Oncology
Seagen’s medicines, late-stage development programs and pioneering expertise in Antibody-Drug Conjugates (ADCs) strongly complement Pfizer’s Oncology portfolio
Seagen expected to contribute more than $10 billion in risk-adjusted revenues in 2030
Pfizer and Seagen to hold analyst and investor call at 8 a.m. EDT today

NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise value of $43 billion. The Boards of Directors of both companies have unanimously approved the transaction. Continue reading

11Mar/23

New Research in JNCCN Highlights the Negative Impact of Continued Exclusion of Racial Groups from Research on Cancer Genomics

New research in the March 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights how the lack of genomic research for people with African ancestry, particularly those from the Sub-Saharan region, is hampering efforts to reduce disparities for people with cancer. In a first-of-its-kind study, the researchers evaluated molecular genetic results for 113 Black South African men diagnosed with advanced prostate cancer to find evidence for increased and potentially unique genetic testing recommendations. Continue reading

06Mar/23

icometrix & Queen Mary University of London receive prestigious AI Award from the National Institute for Health and Care Research (NIHR) to investigate the impact of AI applied to MRI in the care of people with multiple sclerosis (MS)

icometrix is proud to announce that, together with Queen Mary University of London (QMUL), it has been awarded the prestigious AI Award in Health and Care. This collaborative program will investigate the impact of AI on the assessment of MRI and decision making in the context of multi-disciplinary team meetings for people with MS. It is hoped that this research will lead to better care for people with MS (pwMS). Continue reading

14Feb/23

Healthy.io Awarded Three New U.S. Patents for Wound-Image Technology

Healthy.io, the global leader in transforming the smartphone camera into a medical device, announced today that the U.S. Patent and Trademark Office (USPTO) has awarded the company three patents for the technology behind its Minuteful Wound app. The app enables nurses and healthcare assistants to scan chronic wounds using a standard smartphone camera, with the simple process of shooting an ordinary five-second video. Following this scan, the app runs a set of computer-vision and deep-learning algorithms to analyze the data and translate it into clinical outputs. These include a 3D reconstruction of the wound area, a breakdown of the state of the tissues, and the exact size of the wound. Continue reading

14Feb/23

Study Reveals How CBD Counters Epileptic Seizures

A study reveals a previously unknown way in which cannabidiol (CBD), a substance found in cannabis, reduces seizures in treatment-resistant forms of pediatric epilepsy.

Led by researchers at NYU Grossman School of Medicine, the new study found that CBD blocked signals carried by a molecule called lysophosphatidylinositol (LPI). Found in brain cells called neurons, LPI is thought to amplify nerve signals as part of normal function, but can be hijacked by disease to promote seizures. Continue reading

30Jan/23

Ellison Institute Submits Planning Application for Oxford Campus

The Lawrence J. Ellison Institute for Transformative Medicine submitted a planning application to Oxford City Council for a new research and development facility designed by Foster + Partners and devoted to re-imagining and redefining cancer treatment whilst enhancing overall human health, as well as global health policy. The proposed layout represents an integrated and flexible approach, with research laboratories, a clinic, educational spaces, and auditoriums together with multifunctional areas arranged to encourage collaboration. Continue reading

26Dec/22

ANEW MEDICAL Receives Notification of Issuance of Alzheimer’s Gene Therapy Patent and Claims by the European Patent Organization (EPO)

ANEW MEDICAL, INC., a technology and medical product holding company (OTC: LEAS) (“ANEW” or the “Company”) received notification by the EPO of its intention to grant a patent titled “Secreted Splicing Variant of Mammalian Klotho as a Medicament for Cognition and Behaviour Impairments” to Universitat Autonomous De Barcelona (UAB) and Institucio Catalana De Recerca Estudis Avancats (ICREA) of Barcelona, Spain. The technology was licensed on an exclusive worldwide basis in 2022 from UAB and ICREA by ANEW MEDICAL. Continue reading

21Dec/22

Why do people feel lonely at Christmas? Here’s what the research says

Andrea Wigfield, Sheffield Hallam University and John Ratcliffe, Sheffield Hallam University

Christmas is said to be a time for connecting with friends, family and having fun. But it can also be time of loneliness. Indeed, the results of a 2018 survey looking at loneliness during Christmas time in the UK revealed that 17% of people felt more lonely over the festive period.

Continue reading

15Dec/22

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children’s Cancers

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is working on new NCCN Harmonized Guidelines™ for Sub-Saharan Africa, in collaboration with the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the Clinton Health Access Initiative (CHAI). The organizations are part of Allied Against Cancer, a global multi-sector effort to improve resource-stratified access to life-saving cancer care in Sub-Saharan Africa. Continue reading